Huimin Yan

Dr. Huimin Yan


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 December 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
XZXinyu Zhang
Xinyu Zhang
XFXin Fu
Xin Fu
TLTianyu Li
Tianyu Li
HYHuimin Yan
Huimin Yan
Many studies have investigated the association between the level of myeloid derived suppressor cells (MDSCs) and clinical features and prognosis of hepatocellular carcinoma (HCC), but the results remain controversial. This systematic review and meta-analysis was conducted to summarize all available data and estimate the relationship. A comprehensive literature review was carried out using Medline, Embase and Web of Science database through December 2018 to identify relevant studies. The standardized mean difference (SMD) and the hazard ratio (HR) with 95% confidence interval (CI) were utilized for evaluating continuous outcomes and survival analysis, respectively. All statistical analyses were performed by STATA 14.0 software. A total of 13 studies with 1002 HCC patients were included in the meta-analysis. Overall, the proportion of MDSCs in HCC patients was higher than that in healthy controls (SMD = 4.49, 95% CI = 2.53–6.46, P<0.001), and patients with chronic liver disease (SMD = 3.41, 95% CI = 1.58–5.24, P<0.001). Subgroup analysis based on the phenotypes of MDSCs and geographical areas showed similar results. However, the frequency of MDSCs was not affected by the treatment with conventional approaches for HCC (SMD = -0.25, 95% CI = -0.57–0.06, P = 0.119). Moreover, increased MDSCs level was significantly associated with poorer overall survival (HR = 2.36, 95% CI = 1.70–3.29, P<0.001) and recurrence-free survival (HR = 2.72, 95% CI = 1.70–4.35, P<0.001), but not significantly correlated with any clinicopathological parameters. The results of this systematic review suggest that elevated MDSCs level appears to be associated with an increased risk for disease progression and poor prognosis for HCC.

1 April 2020 in Medicine
Verified
Journal Article
Open access
HYHuimin Yan
Huimin Yan
XZXinyu Zhang
Xinyu Zhang
YXYi Xu
Yi Xu
Background: microRNAs have drawn more attention due to their function on the inflammatory process. The association between microRNA-21 (miR-21) expression and risk of inflammatory bowel diseases (IBD) remain inconclusive. This study was aimed to acquire a more exact estimation of this relationship. Methods: Relevant studies were identified through searching PubMed, Embase, Wanfang, and China National Knowledge Infrastructure database. Pooled standardized mean difference and 95% confidence intervals were calculated using a random-effect model. Publication bias test, sensitivity analysis and subgroup analysis were carried out. Results: A total of 20 relevant articles comprising 540 patients with ulcerative colitis (UC), 459 patients with Crohn disease (CD) and 511 non-IBD controls were included in this analysis. The expression of miR-21 was significantly increased in colon tissue of both UC and CD patients compared with non-IBD controls. However, there were no significant differences between patients with UC and CD. Moreover, increased miR-21 expression was associated with disease activity status in UC patients, but not in CD patients. Conclusions: This meta-analysis demonstrates that the higher miR-21 expression in colon tissue is positively associated with the development of UC and CD, and miR-21 might serve as a disease marker of IBD.

1 October 2018 in Clinics and Research in Hepatology and Gastroenterology
Verified
Journal Article
Closed access
YLY. Lv
Y. Lv
MCM. Cui
M. Cui
ZLZ. Lv
Z. Lv
JLJ. Lu
J. Lu
XZX. Zhang
X. Zhang
HYHuimin Yan
Huimin Yan

1 January 2022 in Journal of Food Composition and Analysis
Verified
Journal Article
Closed access
YXYing Xu
Ying Xu
XXXiaofei Xie
Xiaofei Xie
WZWenwen Zhang
Wenwen Zhang
HYHuimin Yan
Huimin Yan
YPYalin Peng
Yalin Peng
GZGuanghong Zhou
Guanghong Zhou

1 January 2020 in BioMed Research International
Verified
Journal Article
Open access
TLTianyu Li
Tianyu Li
XZXinyu Zhang
Xinyu Zhang
ZLZhuo Lv
Zhuo Lv
LGLi Gao
Li Gao
HYHuimin Yan
Huimin Yan
Background and Aim. Myeloid‐derived suppressor cells (MDSCs) have attracted attention due to their important role in tumor immune escape. Several studies have investigated the involvement of MDSCs into hepatocellular carcinoma (HCC); however, due to the difference of MDSC phenotype, patient types, and sample source among the studies, the results were inconsistent and controversial. The present study aimed to confirm the expression and clinical significance of MDSCs in HBV‐related HCC patients. Methods. The percentages of MDSCs, IFN‐γ‐producing CD4 and CD8 T cells in the peripheral blood of HCC patients, chronic hepatitis B (CHB) patients, and healthy controls (HC) were determined by flow cytometry. The serum concentrations of IL‐10 and TNF‐α were determined by ELISA. The association of the percentages of MDSCs with tumor burden, liver function parameters, systemic inflammation‐related indexes, and IFN‐γ‐producing T cells was assessed. Results. The percentages of MDSCs and PMN‐MDSCs were significantly higher in HCC patients than those in CHB patients and HC. The level of MDSCs was correlated with indirect bilirubin and prealbumin, as well as systemic inflammation response index, monocyte/lymphocyte ratio, and monocyte counts. The frequency of IFN‐γ‐producing CD8 T cells of HCC patients was lower than that of HC. However, there was no relationship between MDSCs and IFN‐γ‐producing CD8 T cells. The level of IL‐10 in HCC patients was significantly higher than that in CHB patients. Conclusion. MDSCs seem to play an important role in the process leading from chronic HBV infection to HCC. Early inhibiting these cells could affect tumor progression.

8 May 2017 in Journal of Clinical Laboratory Analysis
Verified
Journal Article
Closed access
PDF file
MCMeilan Cui
Meilan Cui
YLYing Lv
Ying Lv
JLJianhua Lu
Jianhua Lu
WZWei Zhang
Wei Zhang
YDYuanyuan Duan
Yuanyuan Duan
HYHuimin Yan
Huimin Yan